FDA Approves First mRNA Flu Vaccine | Albany News

FDA just approved the first mRNA flu vaccine, mFlusiva, for adults 50+, marking a major leap in flu prevention. Developed by Moderna, it’s set to hit shelves soon for next season and uses cutting-edge tech that lets scientists design vaccines in months—not years—by teaching your immune system to recognize flu proteins without touching your DNA. Early trials show it outperforms traditional shots, especially for older adults. While full approval is granted for ages 50–64, those 65+ are getting fast-track status as studies wrap up. Pharmacies await supply and insurance details before rollout—so don’t expect it at your local store right away, but it’s coming. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/502f2a80ba608868